Atlas Trials

Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency

Clinical trial NCT02722304 · TERMINATED

Trial details

NCT number
NCT02722304
Sponsor
Baxalta now part of Shire
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary DiseaseAlpha1-antitrypsin Deficiency
Start date
2016-11-02
Primary completion
2018-09-14
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.